封面
市场调查报告书
商品编码
1741280

现实世界数据 (RWD) 市场(按组件、应用、最终用户和地区)

Real World Data (RWD) Market, By Component, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年真实世界数据 (RWD) 市场规模估计为 23.8 亿美元,预计到 2032 年将达到 61 亿美元,2025 年至 2032 年的复合年增长率为 14.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 23.8亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 14.40% 2032年价值预测 61亿美元

真实世界数据在理解和应对各行各业的复杂挑战中发挥着至关重要的作用。它指的是从现实世界中收集的信息,包括人口统计、经济指标、医疗记录和环境因素。与模拟数据或理论数据不同,全球真实世界数据 (RWD) 能够洞察实际事件、行为和趋势。这使得研究人员、政策制定者和企业能够做出明智的决策,开发准确的模型并实施有效的策略。随着先进技术的出现和大规模数据可用性的提高,全球真实世界数据 (RWD) 分析在揭示模式、识别相关性和产生可操作知识以推动创新和改善各个领域的成果方面变得越来越有价值。真实世界数据市场是指从传统临床试验以外的各种来源收集和分析数据。这些资讯来源包括电子健康记录、保险理赔资料、病患登记册,甚至穿戴式装置的资料。这些数据被用于医疗保健决策和策略,以改善患者治疗效果并推动医疗保健产业的创新。

市场动态:

预计在预测期内,市场上新产品的不断涌现将推动市场成长。例如,2022年11月,领先的分散式和混合式临床试验技术解决方案供应商Castor宣布推出旨在简化上市后临床试验的新产品。凭藉其不断扩大的全球覆盖范围、真实世界数据 (RWD) 的整合以及临床试验流程的自动化,Castor的最新产品可将临床试验成本降低30%,并将部署时间缩短至平均仅需四週。

然而,资料品质和完整性、资料隐私和法规遵循、资料碎片化、互通性、选择偏差和普遍性等问题预计将在预测期内阻碍全球现实世界资料 (RWD) 市场的成长。

本研究的主要特点

  • 本报告对全球真实世界数据 (RWD) 市场进行了详细分析,并以 2024 年为基准年,展示了预测期 (2025-2032) 的市场规模和復合年增长率。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数,介绍了全球真实世界数据 (RWD) 市场中主要企业的概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员将透过用于分析全球真实世界数据 (RWD) 市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球真实世界资料 (RWD) 市场 - 冠状病毒 (COVID-19) 疫情的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球真实世界数据 (RWD) 市场(按组成部分),2020 年至 2032 年

  • 服务
  • 数据集
  • 临床环境数据
  • 帐单和索赔数据
  • 药房数据
  • 基于註册表的数据
  • 患者主导数据

6. 全球真实世界数据 (RWD) 市场(按应用划分),2020 年至 2032 年

  • 药物研发与核准
  • 市场进入和报销/覆盖范围确定
  • 上市后监测
  • 临床研究
  • 其他用途

7. 全球真实世界数据 (RWD) 市场(按最终用户划分),2020 年至 2032 年

  • 医疗保健付款人
  • 医疗保健提供者
  • 政府
  • 其他的

8. 2020 年至 2032 年全球真实世界数据 (RWD) 市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 南非
      • 中部非洲

第九章 竞争态势

  • IQVIA Holdings Inc.
  • Optum, Inc.(a subsidiary of UnitedHealth Group)
  • Centre Corporation
  • Flatiron Health, Inc.
  • IBM Corporation
  • Tempus Labs Inc.
  • Syneos Health Inc.
  • Evidera, Inc.
  • Palantir Technologies Inc.
  • SAS Institute Inc.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6029

Real World Data (RWD) Market is estimated to be valued at USD 2.38 Bn in 2025 and is expected to reach USD 6.1 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.38 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.40% 2032 Value Projection: USD 6.1 Bn

Real world data plays a crucial role in understanding and addressing complex challenges across various fields. It refers to information gathered from real-life situations, such as demographics, economic indicators, healthcare records, environmental factors, and more. Unlike simulated or theoretical data, global real world data (RWD) offers insights into actual events, behaviours and trends. It enables researchers, policymakers and businesses to make informed decisions, develop accurate models, and implement effective strategies. With the advent of advanced technologies and the growing availability of large-scale data, global real world data (RWD) analysis has become increasingly valuable in uncovering patterns, identifying correlations, and generating actionable knowledge to drive innovation and improve outcomes in diverse domains. The real-world data market refers to the collection and analysis of data from various sources outside of traditional clinical trials. These sources can include electronic health records, insurance claims data, patient registries, and even data from wearable devices. This data is then used to inform healthcare decisions and strategies, improve patient outcomes, and drive innovation in the healthcare industry.

Market Dynamics:

The increasing introduction of new products in the market is expected to drive the growth of the market over the forecast period. For instance, in November 2022, Castor, a leading provider of decentralized and hybrid clinical trial technology solutions, announced a new offering to simplify post-marketing clinical trials. By extending global reach, integrating real-world data (RWD), and automating trial processes, Castor's latest offering can reduce trial costs by 30% and deployment timelines to only 4 weeks on average.

However, data quality and completeness, data privacy and regulatory compliance, data fragmentation, and interoperability and selection bias and generalizability are expected to hamper growth of the global real world data (RWD) market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global real world data (RWD) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global real world data (RWD) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include IQVIA Holdings Inc., Optum, Inc. (a subsidiary of UnitedHealth Group), Cerner Corporation, Flatiron Health, Inc., IBM Corporation, Tempus Labs Inc., Syneos Health Inc., Evidera, Inc., Palantir Technologies Inc., SAS Institute Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The real world data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world data (RWD) market

Detailed Segmentation:

  • By Component:
    • Services
    • Datasets
    • Clinical settings Data
    • Claims & Billing Data
    • Pharmacy Data
    • Registry-Based Data
    • Patient-Powered Data
  • By Application:
    • Drug development and approvals
    • Market access and reimbursement/coverage decisions
    • Post-market surveillance
    • Clinical research
    • Other applications
  • By End User:
    • Pharmaceutical and medical device Companies
    • Healthcare payers
    • Healthcare providers
    • Government agencies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • IQVIA Holdings Inc.
    • Optum, Inc. (a subsidiary of UnitedHealth Group)
    • Cerner Corporation
    • Flatiron Health, Inc.
    • IBM Corporation
    • Tempus Labs Inc.
    • Syneos Health Inc.
    • Evidera, Inc.
    • Palantir Technologies Inc.
    • SAS Institute Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Real World Data (RWD) , By Component
    • Market Global Real World Data (RWD), By Application
    • Market Global Real World Data (RWD), By End user
    • Market Global Real World Data (RWD), By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Real World Data (RWD) Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Real World Data (RWD) Market, By Component, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Datasets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinical settings Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Claims & Billing Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pharmacy Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Registry-Based Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Patient-Powered Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Real World Data (RWD) Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Drug development and approvals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Market access and reimbursement/coverage decisions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Post-market surveillance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Clinical research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Other applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Real World Data (RWD) Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
    • Pharmaceutical and medical device Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Healthcare payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Healthcare providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Government agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Real World Data (RWD) Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • South Africa
      • Central Africa

9. Competitive Landscape

  • IQVIA Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Optum, Inc. (a subsidiary of UnitedHealth Group)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Centre Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Flatiron Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IBM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tempus Labs Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Syneos Health Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Evidera, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Palantir Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SAS Institute Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us